Epigenetic silencing of targeted genes is one of the earliest molecular alterations commonly found in prostate neoplasia. Methylation of the CpG-enriched promoter region of GSTP1 has been recognized ...

PRDX6 and GSTP1 identified as promising enzyme targets for neuroblastoma, offering an alternative to retinoic acid differentiation therapy.